Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | F13A1 | P00488 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | THPO | P40225 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1072209 | 0.84 | ALDH1A1 (0.48) | CA2CA1TSHRRELA | |
| SCHEMBL5283332 | 0.84 | ALDH1A1 (0.48) | CA2CA1TSHRRELA | |
| SCHEMBL162507 | 0.78 | BLM (0.38) | LMNACYP2C19PMP22 | |
| SCHEMBL7916760 | 0.77 | PAOX (0.39) | CA2CA1TSHRPAOX | |
| SCHEMBL21800005 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 | |
| SCHEMBL21799926 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 | |
| SCHEMBL21799948 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 | |
| SCHEMBL21799946 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 | |
| SCHEMBL21799834 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 | |
| SCHEMBL22126251 | 0.77 | CA12 (0.56) | CA12F13A1CA2CYP1A2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103570-A1 | ANTIMICROBIAL AND/OR ANTIADHESIVE CROSSLINKING AGENTS AND ANTIMICROBIAL AND/OR ANTIADHESIVE MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103570-A1 | ANTIMICROBIAL AND/OR ANTIADHESIVE CROSSLINKING AGENTS AND ANTIMICROBIAL AND/OR ANTIADHESIVE MEDICAL HYDROGELS FORMED THEREFROM | ITGAM, CD44, KIT | CA12 2861/4885F13A1 968/4885CA2 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.